These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24096482)

  • 1. mTORC1/2 targeted by n-3 polyunsaturated fatty acids in the prevention of mammary tumorigenesis and tumor progression.
    Chen Z; Zhang Y; Jia C; Wang Y; Lai P; Zhou X; Wang Y; Song Q; Lin J; Ren Z; Gao Q; Zhao Z; Zheng H; Wan Z; Gao T; Zhao A; Dai Y; Bai X
    Oncogene; 2014 Sep; 33(37):4548-57. PubMed ID: 24096482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of endometrial cancer by n-3 polyunsaturated fatty acids in preclinical models.
    Zheng H; Tang H; Liu M; He M; Lai P; Dong H; Lin J; Jia C; Zhong M; Dai Y; Bai X; Wang L
    Cancer Prev Res (Phila); 2014 Aug; 7(8):824-34. PubMed ID: 24866178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. n-3 polyunsaturated fatty acids abrogate mTORC1/2 signaling and inhibit adrenocortical carcinoma growth in vitro and in vivo.
    Liu J; Xu M; Zhao Y; Ao C; Wu Y; Chen Z; Wang B; Bai X; Li M; Hu W
    Oncol Rep; 2016 Jun; 35(6):3514-22. PubMed ID: 27035283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.
    Zhang Y; Xu S; Lin J; Yao G; Han Z; Liang B; Zou Z; Chen Z; Song Q; Dai Y; Gao T; Liu A; Bai X
    Breast Cancer Res Treat; 2012 Nov; 136(2):379-88. PubMed ID: 23053656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of n-3/n-6 PUFAs ratio suppresses mTORC1 and prevents colorectal carcinogenesis associated with APC mutation.
    Liu M; Zhou L; Zhang B; He M; Dong X; Lin X; Jia C; Bai X; Dai Y; Su Y; Zou Z; Zheng H
    Oncotarget; 2016 Nov; 7(47):76944-76954. PubMed ID: 27769066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis.
    Wen ZH; Su YC; Lai PL; Zhang Y; Xu YF; Zhao A; Yao GY; Jia CH; Lin J; Xu S; Wang L; Wang XK; Liu AL; Jiang Y; Dai YF; Bai XC
    Oncogene; 2013 Jan; 32(2):160-70. PubMed ID: 22349822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the synthesis of n-3 PUFAs in fat-1 transgenic mice inhibits mTORC1 signalling and delays surgically induced osteoarthritis in comparison with wild-type mice.
    Huang MJ; Wang L; Jin DD; Zhang ZM; Chen TY; Jia CH; Wang Y; Zhen XC; Huang B; Yan B; Chen YH; Li SF; Yang JC; Dai YF; Bai XC
    Ann Rheum Dis; 2014 Sep; 73(9):1719-27. PubMed ID: 23852692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth.
    Zha X; Hu Z; Ji S; Jin F; Jiang K; Li C; Zhao P; Tu Z; Chen X; Di L; Zhou H; Zhang H
    Cancer Lett; 2015 Apr; 359(1):97-106. PubMed ID: 25578782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models.
    Pignochino Y; Dell'Aglio C; Basiricò M; Capozzi F; Soster M; Marchiò S; Bruno S; Gammaitoni L; Sangiolo D; Torchiaro E; D'Ambrosio L; Fagioli F; Ferrari S; Alberghini M; Picci P; Aglietta M; Grignani G
    Clin Cancer Res; 2013 Apr; 19(8):2117-31. PubMed ID: 23434734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a molecular signature underlying inhibition of mammary carcinoma growth by dietary N-3 fatty acids.
    Jiang W; Zhu Z; McGinley JN; El Bayoumy K; Manni A; Thompson HJ
    Cancer Res; 2012 Aug; 72(15):3795-806. PubMed ID: 22651929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
    Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
    Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammary tumor development is directly inhibited by lifelong n-3 polyunsaturated fatty acids.
    MacLennan MB; Clarke SE; Perez K; Wood GA; Muller WJ; Kang JX; Ma DW
    J Nutr Biochem; 2013 Jan; 24(1):388-95. PubMed ID: 23026490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing effects of prepubertal low- and high-fat n-3 polyunsaturated fatty acid diets on rat mammary tumorigenesis.
    Olivo SE; Hilakivi-Clarke L
    Carcinogenesis; 2005 Sep; 26(9):1563-72. PubMed ID: 15888492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dramatic suppression of colorectal cancer cell growth by the dual mTORC1 and mTORC2 inhibitor AZD-2014.
    Huo HZ; Zhou ZY; Wang B; Qin J; Liu WY; Gu Y
    Biochem Biophys Res Commun; 2014 Jan; 443(2):406-12. PubMed ID: 24309100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity.
    Nogueira LM; Dunlap SM; Ford NA; Hursting SD
    Endocr Relat Cancer; 2012 Feb; 19(1):57-68. PubMed ID: 22143497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIH1D1 interacts with mTOR complex 1 and enhances ribosome RNA transcription.
    Kamano Y; Saeki M; Egusa H; Kakihara Y; Houry WA; Yatani H; Kamisaki Y
    FEBS Lett; 2013 Oct; 587(20):3303-8. PubMed ID: 24036451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) promotes breast cancer progression through enhancing glucose starvation-induced autophagy and Akt signaling.
    Chen Y; Wei H; Liu F; Guan JL
    J Biol Chem; 2014 Jan; 289(2):1164-73. PubMed ID: 24275666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001.
    De Angel RE; Conti CJ; Wheatley KE; Brenner AJ; Otto G; Degraffenried LA; Hursting SD
    Mol Carcinog; 2013 Jun; 52(6):446-58. PubMed ID: 22290600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hind limb ischemic mice via regulating inflammation in vivo.
    Fan W; Cheng K; Qin X; Narsinh KH; Wang S; Hu S; Wang Y; Chen Y; Wu JC; Xiong L; Cao F
    Stem Cells; 2013 Jan; 31(1):203-14. PubMed ID: 23081858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.